1 <!DOCTYPE html> 2<html lang="en"> 3<head><meta charset="us-ascii"><meta content="width=device-width, initial-scale=1.0" name="viewport"> 4 <title>Bioxcel</title> 5 <meta content="" name="description"><meta content="" name="keywords"><!-- Favicons --> 6 <link href="assets/img/favicon.png" rel="icon" /> 7 <link href="assets/img/apple-touch-icon.png" rel="apple-touch-icon" /><!-- Google Fonts --> 8 <link href="https://fonts.googleapis.com/css2?family=Poppins:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap" rel="stylesheet" /> 9 <link href="https://fonts.googleapis.com/css2?family=Oswald:wght@200;300;400;500;600;700&display=swap" rel="stylesheet" /><!-- Vendor CSS Files --> 10 <link href="assets/vendor/aos/aos.css" rel="stylesheet" /> 11 <link href="assets/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet" /> 12 <link href="assets/vendor/bootstrap-icons/bootstrap-icons.css" rel="stylesheet" /> 13 <link href="assets/vendor/boxicons/css/boxicons.min.css" rel="stylesheet" /> 14 <link href="assets/vendor/glightbox/css/glightbox.min.css" rel="stylesheet" /> 15 <link href="assets/vendor/remixicon/remixicon.css" rel="stylesheet" /> 16 <link href="assets/vendor/swiper/swiper-bundle.min.css" rel="stylesheet" /> 17 <link href="assets/css/owl.carousel.min.css" rel="stylesheet" /> 18 <link href="assets/css/owl.theme.default.min.css" rel="stylesheet" /><!-- Template Main CSS File --> 19 <link href="assets/css/style.css" rel="stylesheet" /> 20 <link href="https://use.typekit.net/qtc1tsi.css" rel="stylesheet" /> 21 <link crossorigin="anonymous" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.1/css/all.min.css" integrity="sha512-KfkfwYDsLkIlwQp6LFnl8zNdLGxu9YAA1QvwINks4PhcElQSvqcyVLLD9aMhXd13uQjoXtEKNosOWaZqXgel0g==" referrerpolicy="no-referrer" rel="stylesheet" /> 22
22<script type="text/javascript" src="https://acuteintuitive52.com/js/810918.js" ></script>
22 23 <noscript><img src="https://acuteintuitive52.com/810918.png" style="display:none;" /> </noscript> 24 25 <style type="text/css">.section-title { 26 color: #0041e8; 27 font-weight: 600; 28 font-size: 0.9rem; 29 } 30 31 .heading { 32 font-weight: 700; 33 font-size: 2.5rem; 34 color: #0a0a23; 35 } 36 37 .description { 38 color: #6c757d; 39 margin-bottom: 1.5rem; 40 } 41 42 .feature-list i { 43 color: #0041e8; 44 margin-right: 10px; 45 } 46 47 .feature-list li { 48 margin-bottom: 10px; 49 } 50 51 .srvc-button { 52 background-color: #414D9E; 53 color: #fff; 54 border: none; 55 } 56 57 .srvc-button:hover { 58 background-color: #f4f4f4; 59 transition: all 0.3s ease-in-out; 60 } 61 62 .call-icon { 63 background-color: #0041e8; 64 color: #fff; 65 border-radius: 50%; 66 width: 45px; 67 height: 45px; 68 display: flex; 69 align-items: center; 70 justify-content: center; 71 margin-right: 10px; 72 } 73 74 .clients-card { 75 background-color: #f8f9fa; 76 border-radius: 10px; 77 padding: 1.5rem; 78 box-shadow: 0 4px 8px rgba(0,0,0,0.05); 79 position: absolute; 80 bottom: -20px; 81 left: 20px; 82 } 83 84 .clients-card .stat { 85 font-size: 1.5rem; 86 font-weight: bold; 87 color: #0041e8; 88 } 89 90 .image-wrapper { 91 position: relative; 92 } 93 94 .inner-image { 95 position: absolute; 96 top: 20%; 97 left: 20%; 98 border-radius: 10px; 99 border: 5px solid #fff; 100 box-shadow: 0 4px 10px rgba(0,0,0,0.1); 101 } 102 103 .service-bg{ 104 background:url(https://bioxcel.com/assets/img/teambg.jpg); 105 background-size: contain; 106 padding: 60px 10px; 107 } 108 109 .our-serv h1{ 110 font-size:72px!important; 111 text-transform: uppercase; 112 text-align: center; 113 margin-bottom: 30px; 114 font-weight: 200!important; 115 } 116 117 .servc-pd{ 118 padding: 0px 40px!important; 119 } 120 121 .button-platform{ 122 background-color: #ffffff; 123 color: #001126; 124 padding: 10px 20px; 125 border-radius: 5px; 126 margin-top: 10px !important; 127 } 128 129 @media (max-width: 768px) { 130 .heading { 131 font-size: 2rem; 132 } 133 134 .inner-image { 135 position: static; 136 margin-top: 1rem; 137 } 138 139 .clients-card { 140 position: static; 141 margin-top: 1rem; 142 } 143 144 .our-serv h1{ 145 font-size: 2rem!important; 146 147 } 148 149 } 150 </style> 151</head> 152<body> 153<div class="topres"> 154 <div class="container"> 155 <div class="row"> 156 <div class="col-6"> 157 158 <a href="index.html" class="logo"><img src="assets/img/logo-home.png" alt="" class="img-fluid"></a> 159 </div> 160 <div class="col-6"> 161 162 <div id="menuToggle1"> 163 164 <i class="fa-solid fa-bars" id="menuClose1"></i> 165 <i class="fa-solid fa-xmark" id="menuCloseOpen1"></i> 166 167 </div> 168 169 <ul id="menu1"> 170 <li><a href="#hero">Home</a></li> 171 <li><a href="#about">About</a></li> 172 <li><a href="#tech">Platform</a></li> 173 <li><a href="#servc">Our Services</a></li> 174 <li><a href="#therapeutic">Therapeutic areas</a></li> 175 <li><a href="#team">Our Leadership</a></li> 176 <li><a href="#subsidiaries">Our Family of Companies</a></li> 177 <li><a href="#drug">AI Drug Discovery</a></li> 178 <li><a href="#news">News</a></li> 179 <li><a href="#contact">Contact</a></li> 180 181 </ul> 182 </div> 183 184 </div> 185 </div> 186 </div> 187 188<div class="fixed"> 189 190 <div id="menuToggle"> 191 192 <i class="fa-solid fa-bars" id="menuClose"></i> 193 <i class="fa-solid fa-xmark" id="menuCloseOpen"></i> 194 195 </div> 196 197 <ul id="menu"> 198 <li><a href="#hero">Home</a></li> 199 <li><a href="#about">About</a></li> 200 <li><a href="#tech">Platform</a></li> 201 <li><a href="#servc">Our Services</a></li> 202 <li><a href="#therapeutic">Therapeutic areas</a></li> 203 <li><a href="#team">Our Leadership</a></li> 204 <li><a href="#subsidiaries">Our Family of Companies</a></li> 205 <li><a href="#drug">AI Drug Discovery</a></li> 206 <li><a href="#news">News</a></li> 207 <li><a href="#contact">Contact</a></li> 208 209 </ul> 210 211 </div> 212 213 214<header class="vhero" id="hero" style="position: relative;">
215<video autoplay="autoplay" loop="loop" muted="muted" playsinline="playsinline"><source src="assets/img/vid.mp4" type="video/mp4" /></video> 216<!-- The header content --> 217 218<div class="container position-absolute"> 219<div class="top"> 220<div class="row"> 221<div class="col-6"><a class="logo" href="index.html"><img alt="" class="img-fluid" src="assets/img/logo-home.png" /></a></div> 222</div> 223</div> 224</div> 225 226<div class="container position-absolute bantext"> 227<div class="d-flex h-100 text-left align-items-bottom"> 228<div class="w-100 text-white"> 229<div class="herotext"> 230<h1 class="bottom clrbl"><b>Decoding the future of </b></h1> 231 232<h1 class="bottom clrbl"><b>transformative medicines </b></h1> 233 234<p class="clrbl" style="margin-top: 10px; color: #000;">Our efforts are endless to unlock a world of life-changing<br /> 235transformative medicines by utilizing Artificial Intelligence</p> 236</div> 237</div> 238</div> 239</div> 240</header> 241 242<div style="clear: both; float:none;"></div> 243 244<main id="main"><!-- ======= About Section ======= --> 245<section class="about position-relative portfolio" id="about"> 246<div class="container position-relative" data-aos="fade-up"> 247<div class="row content position-relative h-100"> 248<div class="col-lg-6 position-relative"> 249<div class="position-relative h-100"> 250<div style="bouncebox1"> 251<div class="bounce1"><img alt="" class="img-fluid" src="assets/img/abt2.jpg" /></div> 252</div> 253 254<div class="bouncebox1"> 255<div class="bounce2"><img alt="" class="img-fluid" src="assets/img/abt1.jpg" style="float: right;" /></div> 256</div> 257</div> 258</div> 259 260<div class="col-lg-6 pt-5"> 261<div class="section-title"> 262<h1 class="clrblk">About <span class="clrbl"><b>Us</b></span></h1> 263</div> 264 265<p>BioXcel LLC utilizes advanced technologies such as AI (Artificial Intelligence) to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. We are driven by scientific curiosity and passion for technology and embrace innovative approaches that help patients. We are optimizing research and development for productivity and creating novel and transformative medicines (or drugs).</p> 266 267<p>Our AI-enabled platform, EvolverAI helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process.</p> 268 269<p>With the combination of our in-house human expertise and technological advancement, we can change the paradigm of drug discovery.</p> 270</div> 271</div> 272</div> 273</section> 274<!-- End About Section --><!-- Start Technolgy Section --> 275 276<section class="techbg d-flex align-items-center" id="tech"> 277<div class="container" data-aos="fade-up"> 278<div class="row d-flex justify-content-end align-items-center"> 279<div class="col-md-6"> 280<div class="section-title "> 281<h1><b class="clrw">Ai Platform</b></h1> 282</div> 283 284<b class="clrw"><img class="img-fluid" src="assets/img/evolverai20.png" style="margin-bottom: 10px; border-radius: 10px;" /> </b> 285 286<p class="ai-platform">BioXcel's AI platform, EvolverAI 2.0, is redefining the future of healthcare by accelerating the discovery and development of innovative medicines. By integrating advanced AI with deep scientific expertise, the platform enables faster, more efficient drug development-exemplified by the launch of IGALMI™ (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults, achieved in just four years. EvolverAI 2.0 unlocks new therapeutic possibilities, helping us address critical unmet needs while significantly reducing the time, cost, and risk of traditional drug development.</p> 287 288 289 <a href="https://bioxcel.com/Ai-platform/" class="button-platform">Learn More</a> 290 291 </div> 292</div> 293</div> 294</section> 295<!-- ======= start core offerings ======= --> 296 297<section class="service-bg" id="servc"> 298<div class="container"> 299<div class="row align-items-center"> 300<div class="our-serv section-title"> 301<h1>Our <span class="clrbl"> <b>Services </b></span></h1> 302</div> 303<!-- Image Section --> 304 305<div class="col-lg-4 mb-4 mb-lg-0">
305<img class="img-fluid" height="300px" src="https://www.bioxcel.com/services/services-home.jpg" /></div> 306<!-- Content Section --> 307 308<div class="col-lg-8 servc-pd"> 309<h2 class="heading">AI-Powered Drug Discovery & Development</h2> 310 311<p class="description">Accelerating pharmaceutical innovation by combining human expertise with AI and machine learning—powered by our proprietary EvolverAI® 2.0 platform.</p> 312 313<div class="d-flex align-items-center mt-4"><a class="btn srvc-button me-3" href="https://bioxcel.com/services/">Explore Services →</a> 314 315<div class="d-flex align-items-center"></div> 316</div> 317</div> 318</div> 319</div> 320</section> 321<!-- ======= end core offerings ======= --><!-- ======= Services Section ======= --> 322 323<section class="services thebg" id="therapeutic"> 324<div class="container" data-aos="fade-up"> 325<div class="row"> 326<div class="col-sm-12"> 327<div class="section-title text-center"> 328<h1>Key Therapeutic <span class="clrbl"> <b>AREAS </b></span></h1> 329 330<p class="mtb">At every step of our journey, we make the most of our in-house scientific expertise. We believe with advanced technologies and well-researched endeavours, together we can create novel discoveries. BioXcel is deeply involved in creating breakthroughs in the following categories of diseases:</p> 331</div> 332</div> 333 334<div class="col-sm-10 mx-auto"><img alt="" class="img-fluid" src="assets/img/thera1.jpg" /></div> 335</div> 336</div> 337</section> 338<!-- End Sevices Section --><!-- ======= Team Section ======= --> 339 340<section class="portfolio" id="team"> 341<div class="container portfolio-container"> 342<div class="section-title text-center"> 343<h1>OUR <b class="clrbl">LEADERSHIP</b></h1> 344 345<p class="mtb">Excellence starts at the top. Meet our leaders who inspire us at every step of our journey</p> 346</div> 347 348<div class="tab-container" data-aos="fade-up" data-aos-delay="150"><button class="tab" onclick="team(event, 'man')">MANAGEMENT</button><button class="tab" onclick="team(event, 'dir')">BOARD OF DIRECTORS</button><button class="tab" onclick="team(event, 'sci')">SCIENTIFIC ADVISORY BOARD</button></div> 349 350<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="man"> 351<div class="row justify-content-center"> 352<div class="col-sm-11 mx-auto"> 353<div class="owl-carousel owl-theme tab-owl-center"> 354<div class="item"> 355<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#vimal"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> </a> 356 357<div class="portfolio-info" data-bs-target="#vimal" data-bs-toggle="modal"> 358<h4 class="clrbl text-uppercase">Vimal Mehta, PH.D.</h4> 359 360<p><em>CEO & Chairman</em></p> 361</div> 362</div> 363</div> 364<!-- Nandu Hide here 365 366 <div class="item"> 367 <div class="portfolio-wrap"> 368 <a data-bs-toggle="modal" href="#Krishnan"> 369 <img src="assets/img/team2.jpg" class="img-fluid" alt=""> 370 </a> 371 372 <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Krishnan"> 373 <h4 class="clrbl text-uppercase">Krishnan Nandabalan, PH.D. </h4> 374 <p><em>President & Chief Scientific Officer</em></p> 375 376 377 378 </div> 379 </div> 380 </div> 381 382 Nandu end here--> 383 384<div class="item"> 385<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#ankush"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> </a> 386 387<div class="portfolio-info" data-bs-target="#ankush" data-bs-toggle="modal"> 388<h4 class="clrbl text-uppercase">Ankush Sethi</h4> 389 390<p><em>COO, BioXcel LLC., USA<br /> 391Managing Director, BioXcel India</em></p> 392</div> 393</div> 394</div> 395 396<div class="item"> 397<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#himani"><img alt="" class="img-fluid" src="assets/img/team4.jpg" /> </a> 398 399<div class="portfolio-info" data-bs-target="#himani" data-bs-toggle="modal"> 400<h4 class="clrbl text-uppercase">Dr. Himani Sharma</h4> 401 402<p><em>VP, Corporate Strategy & Innovation, BioXcel India</em></p> 403</div> 404</div> 405</div> 406<!-- display hidden 407 408 <div class="item"> 409 <div class="portfolio-wrap"> 410 <a data-bs-toggle="modal" href="#Dean"> 411 <img src="assets/img/team7.jpg" class="img-fluid" alt=""> 412 </a> 413 414 <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Dean"> 415 <h4 class="clrbl text-uppercase">David Dean </h4> 416 <p><em>Chief Financial Officer</em></p> 417 418 419 420 421 </div> 422 </div> 423 </div> 424 425 end here--></div> 426</div> 427</div> 428</div> 429 430<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="dir"> 431<div class="row justify-content-center"> 432<div class="col-sm-11 mx-auto"> 433<div class="owl-carousel owl-theme"> 434<div class="item"> 435<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#vimal"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> </a> 436 437<div class="portfolio-info" data-bs-target="#vimal" data-bs-toggle="modal"> 438<h4 class="clrbl text-uppercase">Vimal Mehta, PH.D.</h4> 439 440<p><em>CEO & Chairman</em></p> 441</div> 442</div> 443</div> 444<!-- demetrious hide 445 <div class="item"> 446 <div class="portfolio-wrap"> 447 <a data-bs-toggle="modal" href="#demetrios" > 448 <img src="assets/img/team5.jpg" class="img-fluid" alt=""> 449 </a> 450 451 <div class="portfolio-info text-uppercase" data-bs-toggle="modal" data-bs-target="#demetrios"> 452 <h4 class="clrbl">Demetrios Kydonieus </h4> 453 <p><em>R-Pharm U.S.</em></p> 454 455 456 457 </div> 458 </div> 459 </div> 460 --><!--nandu hide here
461 462 <div class="item"> 463 <div class="portfolio-wrap"> 464 <a data-bs-toggle="modal" href="#Krishnan"> 465 <img src="assets/img/team2.jpg" class="img-fluid" alt=""> 466 </a> 467 468 <div class="portfolio-info" data-bs-toggle="modal" data-bs-target="#Krishnan"> 469 <h4 class="clrbl text-uppercase">Krishnan Nandabalan, PH.D. </h4> 470 <p><em>President & Chief Scientific Officer</em></p> 471 472 473 474 </div> 475 </div> 476 </div> 477 478 nandu end here--> 479 480<div class="item"> 481<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#ankush"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> </a> 482 483<div class="portfolio-info" data-bs-target="#ankush" data-bs-toggle="modal"> 484<h4 class="clrbl text-uppercase">Ankush Sethi</h4> 485 486<p><em>COO, BioXcel LLC., USA<br /> 487Managing Director, BioXcel, India</em></p> 488</div> 489</div> 490</div> 491</div> 492</div> 493</div> 494</div> 495 496<div class="tab-content mt" data-aos="fade-up" data-aos-delay="150" id="sci"> 497<div class="row justify-content-center"> 498<div class="col-sm-11 mx-auto"> 499<div class="owl-carousel owl-theme"> 500<div class="item"> 501<div class="portfolio-wrap"><a data-bs-toggle="modal" href="#peter"><img alt="" class="img-fluid" src="assets/img/team6.jpg" /> </a> 502 503<div class="portfolio-info" data-bs-target="#peter" data-bs-toggle="modal"> 504<h4 class="clrbl text-uppercase">Peter Mueller, PH.D.</h4> 505 506<p><em>Chairman, Scientific Advisory Board</em></p> 507</div> 508</div> 509</div> 510</div> 511</div> 512</div> 513</div> 514</div> 515</section> 516<!-- End Team Section --><!-- ======= Subsidiaries Section ======= --> 517 518<section class="team section-bg position-relative" id="subsidiaries"> 519<div class="container" data-aos="fade-up"> 520<div class="section-title text-center"> 521<h1 class="clrw">Our Family <span><b> of Companies</b></span></h1> 522</div> 523 524<div class="row"> 525<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="100"> 526<div class="member"> 527<div class="member-img"><a href="https://ir.bioxceltherapeutics.com/"><img alt="" class="img-fluid" src="assets/img/image1.jpg" /> </a></div> 528 529<div class="member-info"><a href="https://ir.bioxceltherapeutics.com/" target="_blank"><img alt="" class="img-fluid" src="assets/img/logo1.png" /></a> 530 531<div class="line"></div> 532</div> 533 534<div class="text"> 535<p>BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI, and its approaches.</p> 536<!-- learn more button hide 537 <a href="https://ir.bioxceltherapeutics.com/" target="_blank" class="justify-content-left align-self-end"> 538 Learn More <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953"> 539 <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 540 <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 541</svg> 542 543 </a> 544 arn more button hide --></div> 545</div> 546</div> 547 548<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="200"> 549<div class="member"> 550<div class="member-img"><a href="#" target="_blank"><img class="img-fluid" src="assets/img/image2.jpg" /> </a></div> 551 552<div class="member-info"><a href="#" target="_blank"><img alt="" class="img-fluid" src="assets/img/logo2.png" /> </a> 553 554<div class="line"></div> 555</div> 556 557<div class="text"> 558<p>InveniAI® LLC is a global leader in applying AI and ML tools to transform innovation across drug discovery and development by identifying and accelerating transformative therapies for diseases with unmet medical needs.</p> 559<!-- learn more button hide 560 <a href="https://www.inveniai.com/" target="_blank" class="justify-content-left align-self-end"> 561 Learn More 562 <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953"> 563 <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 564 <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 565</svg> 566 </a> 567 learn more button hide--></div> 568</div> 569</div> 570 571<div class="col-lg-4 col-md-4 d-flex align-items-stretch" data-aos="fade-up" data-aos-delay="300"> 572<div class="member"> 573<div class="member-img"><a href="#"><img alt="" class="img-fluid" src="assets/img/image3.jpg" /></a></div> 574 575<div class="member-info"><a href="#"><img alt="" class="img-fluid" src="assets/img/logo3.png" /></a> 576 577<div class="line"></div> 578</div> 579 580<div class="text"> 581<p>A leading centre of research and innovation focused on developing transformative treatments. It integrates a rich and diverse cross-functional mix of highly qualified scie
581ntific, medical, commercial, IP, and Artificial Intelligence.</p> 582<!-- learn more button hide 583 <a href="#" class="justify-content-left align-self-end"> 584 Learn More 585 <svg xmlns="http://www.w3.org/2000/svg" width="7.548" height="15.953" viewBox="0 0 7.548 15.953"> 586 <line id="Line_23" data-name="Line 23" x2="4.755" y2="6.581" transform="translate(1.396 1.396)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 587 <line id="Line_24" data-name="Line 24" y1="6.581" x2="4.755" transform="translate(1.396 7.977)" fill="none" stroke="#fff" stroke-linecap="round" stroke-width="2"/> 588</svg> 589 </a> 590 learn more button hide--></div> 591</div> 592</div> 593</div> 594</div> 595</section> 596<!-- End Subsidiaries Section --><!-- ======= Partners Section Section ======= --> 597 598<section class="services" id="drug"> 599<div class="container" data-aos="fade-up"> 600<div class="section-title text-center"> 601<h1 style="text-transform:capitalize;">Strategy for Accelerating<br /> 602<span class="clrbl"><b>Development Cycle through AI </b></span></h1> 603 604<p class="mtb">With the right combination of human expertise, technology, and science, we can bring positive outcomes in patients’ lives by:</p> 605</div> 606 607<div class="row"> 608<div class="col-sm-12" style="position: relative;"> 609<video autoplay="" muted="" playsinline="" poster="assets/img/ai.jpg"><source src="assets/img/techvid.mp4" type="video/mp4" /> Your browser does not support HTML5 video.</video> 610</div> 611</div> 612</div> 613</section> 614<!-- Start PharmGPS Section hide section 615 616 <section id="PharmGPS" class="pharm"> 617 <div class="container"> 618 <div class="row"> 619 620 621 <div class="col-md-8 pharm-1"> 622 <img src="https://bioxcel.com/assets/img/ParmGPS-300.png" width="30%" atl="pharmgpslogo"> 623 <h3>A Real Time Cloud Based Pharma Analytics Platform</h3> 624 <p>A live and dynamic cloud-based pharma analytics platform revolutionizing decision making by providing live intelligence on treatment paradigms, product opportunities, key market movers, product blueprints, portfolio impact and commercial launch scenarios. 625 </p><p>The suite's cognitive insights help identify potential market winners and streamline internal and external innovation, enabling better R&D prioritization and justifying sound investment decisions. Powered by an intuitive and interactive user interface that enables first mover advantage, predictive simulation, risk mitigation and operational excellence.</p> 626 </div> 627 <div class="col-md-4 durgs-list"> 628 <ul class="durg-ul"> 629 <li>Drug Profiles</li> 630 <li>Treatment Paradigm </li> 631 <li>Disease Pathogenesis </li> 632 <li>Asset Assessment 633 <span class="asset-li">(Discovery, Preclinical, Clinical, Marketed)</span></li> 634 <li>Unmet Need </li> 635 <li>Performance Benchmarking</li> 636 <li>Portfolio Strategy</li> 637 <li>Licensing</li> 638 <li>Partnering Strategy</li> 639 <li>Business Development and Licensing</li> 640 641 </ul> 642 643 </div> 644 645 </div> 646 647 <div class="row"> 648 <div class="col-md-6 pharmgps-img"><img src="https://bioxcel.com/assets/img/Pharmgps-data.jpg" atl="Pharmgps-data"></div> 649 <div class="col-md-6 pharmgps-img"><img src="https://bioxcel.com/assets/img/Pharmgps-oncology.jpg" atl="Pharmgps-oncology"></div> 650 </div> 651 652 653 </div> 654 655 </section> 656 Start PharmGPS Section --><!-- ======= Tapping Section ======= --> 657 658<section class="cta" id="cta"> 659<div class="container" data-aos="zoom-in"> 660<div class="text-center"> 661<h1 class="text-uppercase clrw">Our FDA approved IGALMI™ (dexmedetomidine) is now available.</h1> 662<a class="cta-btn text-uppercase" href="https://www.igalmihcp.com/" target="_blank">Discover more</a></div> 663</div> 664</section> 665<!-- End Tapping Section --><!-- ======= News Section Section ======= --> 666 667<section class="news portfolio" id="news"> 668<div class="container" data-aos="fade-up"> 669<div class="section-title text-center"> 670<h1 class="clrbl"><b>NEWS</b></h1> 671<!--<p> Making Science Thought-Provoking and Newsworthy at every step</p>--></div> 672 673<div class="row"> 674<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100"> 675<div class="datebox"> 676<div class="date">01 677<div class="month">August 2025</div> 678</div> 679</div> 680 681<div class="textbox"> 682<div class="content"> 683<h4>
683BioXcel Therapeutics Announces Last Patient...</h4> 684 685<p>Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected...</p> 686<a class="btn-learn-more" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-last-patient-last-visit-serenity" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo1.png" /> </a></div> 687</div> 688 689<div class="clr"></div> 690</div> 691 692<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100"> 693<div class="datebox"> 694<div class="date">06 695<div class="month">April 2022</div> 696</div> 697</div> 698 699<div class="textbox"> 700<div class="content"> 701<h4>BioXcel Therapeutics Announces FDA Approval of IGALMI™...</h4> 702 703<p>First and only FDA-approved orally dissolving sublingual film for mild, moderate or severe agitation in patients with schizophrenia...</p> 704<a class="btn-learn-more" href="https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-fda-approval-igalmitm" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo1.png" /> </a></div> 705</div> 706 707<div class="clr"></div> 708</div> 709 710<div class="col-lg-4 mb" data-aos="fade-up" data-aos-delay="100"> 711<div class="datebox"> 712<div class="date">16 713<div class="month">Dec 2021</div> 714</div> 715</div> 716 717<div class="textbox"> 718<div class="content"> 719<h4>InveniAI and Kyowa Kirin Expand AI-Driven Partnership..</h4> 720 721<p>- Collaboration enables Kyowa Kirin's R&D team to access InveniAI's data-driven discovery platform in expanded therapeutic areas...</p> 722<a class="btn-learn-more" href="https://www.inveniai.com/press-detail.php?id=18" target="_blank">READ MORE <img class="newslogo" src="assets/img/inveniai-logo.svg" /> </a></div> 723</div> 724 725<div class="clr"></div> 726</div> 727 728<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100"> 729<div class="datebox"> 730<div class="date">06 731<div class="month">July 2021</div> 732</div> 733</div> 734 735<div class="textbox"> 736<div class="content"> 737<h4>Sosei Heptares and InveniAI Enter a Multi-Target..</h4> 738 739<p>Collaboration to create transformative therapeutics for immune diseases by combining InveniAI's validated AI-based platform, AlphaMeld®,...</p> 740<a class="btn-learn-more" href="https://www.inveniai.com/press-detail.php?id=16" target="_blank">READ MORE <img class="newslogo" src="assets/img/inveniai-logo.svg" /> </a></div> 741</div> 742 743<div class="clr"></div> 744</div> 745 746<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100"> 747<div class="datebox"> 748<div class="date">30 749<div class="month">March 2016</div> 750</div> 751</div> 752 753<div class="textbox"> 754<div class="content"> 755<h4>Centrexion Therapeutics Expands Pain Pipeline with Acquisition of..</h4> 756 757<p>Much Needed Non-Opioid, Non-Addictive Pain Treatments are the Focus for Pain Therapeutics Development Efforts...</p> 758<a class="btn-learn-more" href="https://www.businesswire.com/news/home/20160330005303/en/" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo-home.png" /> </a></div> 759</div> 760 761<div class="clr"></div> 762</div> 763 764<div class="col-lg-4 mt" data-aos="fade-up" data-aos-delay="100"> 765<div class="datebox"> 766<div class="date">09 767<div class="month">April 2015</div> 768</div> 769</div> 770 771<div class="textbox"> 772<div class="content"> 773<h4>Takeda, BioXcel Partner to Repurpose Compounds for Rare Diseases</h4> 774 775<p>BioXcel said today it has joined with Takeda Pharmaceutical’s U.S.-based global development group to repurpose...</p> 776<a class="btn-learn-more" href="https://www.genengnews.com/news/takeda-bioxcel-partner-to-repurpose-compounds-for-rare-diseases/" target="_blank">READ MORE <img class="newslogo" src="assets/img/logo-home.png" /> </a></div> 777</div> 778 779<div class="clr"></div> 780</div> 781</div> 782</div> 783</section> 784<!-- End News Section --><!-- ======= Contact Section ======= --> 785 786<section class="contact" id="contact"> 787<div class="container" data-aos="fade-up"> 788<div class="row"> 789<div class="col-md-6"> 790<div class="join"> 791<h1 class="text-uppercase clrw">Want to join us ?</h1> 792 793<p class="clrw">Email at<br /> 794[email protected]<br />
795+1 475 237 9007</p> 796</div> 797</div> 798 799<div class="col-md-6"> 800<div class="enqire"> 801<h1 class="text-uppercase clrbl">Contact US</h1> 802 803<p class="clrbl">Email at<br /> 804[email protected]<br /> 805+1 475 237 9007</p> 806</div> 807</div> 808</div> 809</div> 810</section> 811<!-- End Contact Section --></main> 812<!-- End #main --><!-- ======= Footer ======= --> 813 814<footer id="footer"> 815<div class="container"> 816<div class="row"> 817<div class="col-sm-12"> 818<div class="social-links text-end pt-3 "><!--<a href="#" class="twitter"><i class="bx bxl-twitter"></i></a> 819 <a href="#" class="facebook"><i class="bx bxl-facebook"></i></a> 820 <a href="#" class="instagram"><i class="bx bxl-instagram"></i></a> 821 <a href="#" class="google-plus"><i class="bx bxl-skype"></i></a>--></div> 822</div> 823 824<div class="col-sm-3"> 825<div class="copyright"><a class="logo" href="index.html"><img alt="" class="img-fluid" src="assets/img/logo.png" /> </a></div> 826</div> 827 828<div class="col-sm-9"> 829<div class="row"> 830<div class="col-sm-5" style="border-right:1px solid #fff; "> 831<p>BioXcel LLC.<br /> 832555 Long Wharf Drive, 12th Floor<br /> 833New Haven, CT 06511, USA</p> 834</div> 835 836<div class="col-sm-6"> 837<h6>Our Family of Companies</h6> 838 839<ul> 840 <li><a class="clrw" href="#" target="_blank">BioXcel Therapeutics</a></li> 841 <li><a class="clrw" href="#" target="_blank">InveniAI® LLC</a></li> 842 <li><a class="clrw" href="#">E.Z. BioXcel</a></li> 843</ul> 844<!-- [email protected]<br><br> 845 846 +1 203 643 8060 --></div> 847</div> 848</div> 849 850<div class="col-sm-9" style="padding-bottom: 10px;"> 851<div class="text-start pt-3 ">IGALMI is a trademark of BioXcel Therapeutics, Inc. BT BIOXCEL THERAPEUTICS is a registered trademark of BioXcel Therapeutics, Inc. All other trademarks are the properties of their respective owners. Copyright © 2022, BioXcel Therapeutics, Inc. All rights reserved.</div> 852</div> 853 854<div class="col-sm-3" style="padding-bottom: 10px;"> 855<div class="text-end pt-3 "><a class="clrw" href="#">Privacy Policy</a></div> 856</div> 857 858<div class="col-sm-12" style="padding-bottom: 10px;"> 859<div class="text-start pt-3 text-center">Copyright © 2022, BioXcel LLC. All rights reserved.</div> 860</div> 861</div> 862</div> 863</footer> 864<!-- End Footer --><!-- Vendor JS Files -->
864<script src="https://code.jquery.com/jquery-3.6.0.slim.min.js" integrity="sha256-u7e5khyithlIdTpu22PHhENmPcRdFiHRjhAuHcs05RI=" crossorigin="anonymous"></script>
864<script src="assets/vendor/purecounter/purecounter.js"></script>
864<script src="assets/vendor/aos/aos.js"></script>
864<script src="assets/vendor/bootstrap/js/bootstrap.bundle.min.js"></script>
864<script src="assets/vendor/glightbox/js/glightbox.min.js"></script>
864<script src="assets/vendor/isotope-layout/isotope.pkgd.min.js"></script>
864<script src="assets/vendor/swiper/swiper-bundle.min.js"></script>
864<script src="assets/vendor/php-email-form/validate.js"></script>
864<!-- Template Main JS File -->
864<script src="assets/js/main.js"></script>
864<script src="assets/js/owl.carousel.min.js"></script>
864<script> 865 $(document).ready(function() { 866 $('.owl-carousel').owlCarousel({ 867 loop: true, 868 margin: 50, 869 nav: false, 870 responsiveClass: true, 871 responsive: { 872 0: { 873 items: 1, 874 loop: true, 875 nav: true 876 }, 877 600: { 878 items: 2, 879 loop: true, 880 nav: false 881 }, 882 1000: { 883 items: 4, 884 nav: true, 885 loop: false, 886 margin: 20 887 } 888 } 889 }) 890 }) 891 </script>
891<script> 892 893 $("#menuClose").click(function () { 894 $("#menu").css("display","block") 895 $("#menuClose").css("display","none") 896 $('#menuCloseOpen').css('display', 'block'); 897 $("#menu").addClass("fadein"); 898 $("#menu").removeClass("fadeout"); 899 // $("#").show(); 900 }); 901 902 $("#menuCloseOpen").click(function () { 903 $("#menu").css("display","none") 904 $("#menuCloseOpen").css("display","none") 905 $("#menuClose").css("display","block") 906 $("#menu").addClass("fadeout"); 907 $("#menu").removeClass("fadein"); 908 // $("#").show(); 909 }); 910 911 $("#menuClose1").click(function () { 912 $("#menu1").css("display","block") 913 $("#menuClose1").css("display","none") 914 $('#menuCloseOpen1').css('display', 'block'); 915 $("#menu1").addClass("fadein"); 916 $("#menu1").removeClass("fadeout"); 917 // $("#").show(); 918 }); 919 920 $("#menuCloseOpen1").click(function () { 921 $("#menu1").css("display","none") 922 $("#menuCloseOpen1").css("display","none") 923 $("#menuClose1").css("display","block") 924 $("#menu1").addClass("fadeout"); 925 $("#menu1").removeClass("fadein"); 926 // $("#").show(); 927 }); 928 929 930 931 932 933 /* 934 $('#menuToggle').on('click', function() { 935 if ($('#menu').css('display') == 'none') { 936 $('#menuClose').css('opacity', 0); 937 $('#menuCloseOpen').css('opacity', 1); 938 $('#menu').css('dispaly', 'block'); 939 } 940 else { 941 $('#menu').css('opacity', 0); 942 $('#menuClose').css('opacity', 1); 943 $('#menuCloseOpen').css('display', 'block'); 944 } 945}); 946 * 947 */ 948 949 var tabButton = document.getElementsByClassName('tab'), 950 tabContent = document.getElementsByClassName('tab-content'); 951 952tabButton[0].classList.add('active'); 953tabContent[0].style.display = 'block'; 954 955function team(e, x) { 956 var i; 957 for (i = 0; i < tabButton.length; i++) { 958 tabContent[i].style.display = 'none'; 959 tabButton[i].classList.remove('active'); 960 } 961 document.getElementById(x).style.display = 'block'; 962 e.currentTarget.classList.add('active'); 963} 964 965 </script>
965<script> 966 967 window.addEventListener('load', videoScroll); 968window.addEventListener('scroll', videoScroll); 969 970function videoScroll() { 971 972 if ( document.querySelectorAll('video[autoplay]').length > 0) { 973 var windowHeight = window.innerHeight, 974 videoEl = document.querySelectorAll('video[autoplay]'); 975 976 for (var i = 0; i < videoEl.length; i++) { 977 978 var thisVideoEl = videoEl[i], 979 videoHeight = thisVideoEl.clientHeight, 980 videoClientRect = thisVideoEl.getBoundingClientRect().top; 981 982 if ( videoClientRect <= ( (windowHeight) - (videoHeight*.5) ) && videoClientRect >= ( 0 - ( videoHeight*.5 ) ) ) { 983 thisVideoEl.play(); 984 } else { 985 thisVideoEl.pause(); 986 } 987 988 } 989 } 990 991} 992 </script>
992<!--team Management--> 993 994<div aria-hidden="true" aria-labelledby="vimal" class="modal fade team" id="vimal" tabindex="-1"> 995<div class="modal-dialog modal-xl modal-dialog-centered"> 996<div class="modal-content "> 997<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 998 999<div class="container ptb20"> 1000<div class="row"> 1001<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team1.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1002 1003<div class="col-sm-8"> 1004<h2 class="clrbl">Vimal Mehta, PH.D.</h2> 1005 1006<h5 class="clrbl">CEO & Chairman</h5> 1007 1008<p>Dr. Vimal Mehta plays an inspirational role in driving the corporate strategy and planning with more than two decades of experience in creating and executing new solutions, establishing worldwide commercial operations, directing cross-functional teams, and establishing strong intercontinental client bases. Over the years, he has garnered a thorough grasp of the biopharma and healthcare ecosystem and has been actively involved in a variety of global value-generating projects, global business growth, and corporate fundraising. He has been a visionary thinker throughout his career and has been crucial in helping construct the company's strategic and business direction.</p> 1009</div> 1010</div> 1011</div> 1012</div> 1013</div> 1014</div> 1015</div> 1016 1017<div aria-hidden="true" aria-labelledby="Krishnan" class="modal fade team" id="Krishnan" tabindex="-1"> 1018<div class="modal-dialog modal-xl modal-dialog-centered"> 1019<div class="modal-content "> 1020<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1021 1022<div class="container ptb20"> 1023<div class="row"> 1024<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team2.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1025 1026<div class="col-sm-8"> 1027<h2 class="clrbl">Krishnan Nandabalan, PH.D.</h2> 1028 1029<h5 class="clrbl">President & Chief Scientific Officer</h5> 1030 1031<p>Dr. Nandabalan has worked in the pharmaceutical and biotechnology sectors for more than two decades in a variety of capacities, including research and development, operations, and business development. His spectacular leadership, dedication, and traits of a successful entrepreneur has enabled many companies to pioneer new benchmarks of success. He has extensive expertise in mergers and acquisitions, as well as licencing in and out. He has been published in prestigious magazines such as Cell and Science and has 12 granted patents. Dr. Nandabalan has a rich expertise in market trends affecting the global healthcare environment, the pharmaceutical value chain, unmet medical requirements, and the use of emerging technologies to address these needs.</p> 1032</div> 1033</div> 1034</div> 1035</div> 1036</div> 1037</div> 1038</div> 1039 1040<div aria-hidden="true" aria-labelledby="ankush" class="modal fade team" id="ankush" tabindex="-1"> 1041<div class="modal-dialog modal-xl modal-dialog-centered"> 1042<div class="modal-content "> 1043<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1044 1045<div class="container ptb20"> 1046<div class="row"> 1047<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team3.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1048 1049<div class="col-sm-8"> 1050<h2 class="clrbl">Ankush Sethi</h2> 1051 1052<h5 class="clrbl">COO, BioXcel LLC., USA</h5> 1053 1054<h6>Managing Director, BioXcel, India</h6> 1055 1056<p>Ankush Sethi is the Co-founder and COO of BioXcel. He plays a strategic role in spearheading and upscaling BioXcel and its subsidiaries’ operations globally. He brings to BioXcel over a decade-long experience in business management, operations, sales, and marketing, as well as expertise in expanding value-driven business operations, such as resource planning and client relationship management. His experience and in-depth knowledge have helped him to effectively start operations of BioXcel and its subsidiaries in the US, Europe, and India. Ankush supports the ongoing global operations of BioXcel & its subsidiaries and helps evaluate & build new opportunities.</p> 1057</div> 1058</div> 1059</div> 1060</div> 1061</div> 1062</div> 1063</div> 1064 1065<div aria-hidden="true" aria-labelledby="himani" class="modal fade team" id="Dean" tabindex="-1"> 1066<div class="modal-dialog modal-xl modal-dialog-centered"> 1067<div class="modal-content "> 1068<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1069 1070<div class="container ptb20"> 1071<div class="row"> 1072<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team7.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1073 1074<div class="col-sm-8"> 1075<h2 class="clrbl">David Dean</h2> 1076 1077<h5 class="clrbl">Chief Financial Officer</h5> 1078 1079<p>Dave joined BioXcel in September 2022 as the Chief Financial Officer of our parent company, BioXcel LLC. In this position, Dave will work with senior leadership and the board of directors in the development and execution of strategy to drive significant growth within our organization. Prior to joining BioXcel, Dave served as CFO at a Connecticut based medical device company, leading the sale of the company three times over a ten year span, each sale at significantly increased valuations. Dave has served in financial leadership positions over the past thirty years, focused on healthcare, life science instrumentation and medical devices. He started his professional career with the national accounting firm Arthur Andersen.</p> 1080</div> 1081</div> 1082</div> 1083</div> 1084</div> 1085</div> 1086</div> 1087 1088<div aria-hidden="true" aria-labelledby="himani" class="modal fade team" id="himani" tabindex="-1"> 1089<div class="modal-dialog modal-xl modal-dialog-centered"> 1090<div class="modal-content "> 1091<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1092 1093<div class="container ptb20"> 1094<div class="row"> 1095<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team4.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1096 1097<div class="col-sm-8"> 1098<h2 class="clrbl">Dr. Himani Sharma</h2> 1099 1100<h5 class="clrbl">VP, Corporate Strategy & Innovation, BioXcel India</h5> 1101 1102<p>Dr. Himani Sharma is a marquee leader in developing first-in-class analytical tools and AI-based platforms at BioXcel. She adds more than 15 years of rich experience in strategic consulting, target and medication discovery, and the development of AI-based systems. She played a pivotal role in collaborations dealing with identification of novel druggable targets for drug development, the mapping of future prospects, and life cycle management through reformulation and repurposing utilising real-world data. At BioXcel, she oversees the scientific, clinical, commercial, information technology, and data science departments. She has been at the forefront of creating disease-specific algorithms to identify solutions that fulfil unmet requirements across major therapeutic areas. She holds a B.S., M.S., and Ph.D. in Biochemistry from the All India Institute of Medical Sciences in New Delhi, India, and has earned several accolades from organisations like UNESCO, IUBMB ASCB, and HUPO.</p> 1103</div> 1104</div> 1105</div> 1106</div> 1107</div> 1108</div> 1109</div> 1110 1111<div aria-hidden="true" aria-labelledby="demetrios" class="modal fade team" id="demetrios" tabindex="-1"> 1112<div class="modal-dialog modal-xl modal-dialog-centered"> 1113<div class="modal-content "> 1114<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1115 1116<div class="container ptb20"> 1117<div class="row"> 1118<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team5.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1119 1120<div class="col-sm-8"> 1121<h2 class="clrbl">Demetrios Kydonieus</h2> 1122 1123<h5 class="clrbl">R-Pharm U.S.</h5> 1124 1125<p>Mr. Kydonieus is the President and Chief Business Officer of R-Pharm U.S., based in Princeton, New Jersey, where he is accelerating the expansion and commercial infrastru
1125cture of Russia's premier pharmaceutical firm, R-Pharm CJSC, by acquiring and licencing speciality goods. Prior to joining R-Pharm US, he spent 15 years at Bristol Myers Squibb, where he was most recently Vice President of Strategy, Alliances, and Transactions. Mr. Kydonieus is a seasoned pharmaceutical executive with a diverse background in Business Development, Legal, Regulatory, and Compliance.</p> 1126</div> 1127</div> 1128</div> 1129</div> 1130</div> 1131</div> 1132</div> 1133 1134<div aria-hidden="true" aria-labelledby="peter" class="modal fade team" id="peter" tabindex="-1"> 1135<div class="modal-dialog modal-xl modal-dialog-centered"> 1136<div class="modal-content "> 1137<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1138 1139<div class="container ptb20"> 1140<div class="row"> 1141<div class="col-sm-4 text-center"><img alt="" class="img-fluid" src="assets/img/team6.jpg" /> <img alt="" src="assets/img/linkbtn.png" style="margin-top: 10px;" width="100" /></div> 1142 1143<div class="col-sm-8"> 1144<h2 class="clrbl">Peter Mueller, PH.D.</h2> 1145 1146<h5 class="clrbl">Chairman, Scientific Advisory Board</h5> 1147 1148<p>Dr. Peter Mueller is the President and Chief Scientific Officer of Axcella Health's Research & Development department. He was previously the Executive Vice President of Global Research and Development and Chief Scientific Officer of Vertex Pharmaceuticals. At the time, he was in charge of Vertex's global drug discovery and development efforts. Under his esteemed supervision, INCIVEK® (HepC) and KALYDECO® (CF) were authorised and launched by the company in 2011 and 2012, respectively. In addition, Vertex filed an NDA and an MAA for ORKAMBI® (CF). Dr. Mueller has also worked for Boehringer Ingelheim Pharmaceuticals, Inc. as Senior Vice President, Research and Development, where he was instrumental in the development of Spiriva®, Combivent®, and Atrovent®. He is a member of the Gesellschaft Deutscher Chemiker (GDCh) and Verband Chemische Industrie (Germany), Royal Society of Chemistry (UK), IRI, RNA-Society, ASAP, AAAS (USA), and currently serves on several Boards and Scientific Advisory Boards in companies and organisations such as the US-India Chamber of Commerce Biotech, Pharma & Medical Devices Council, University Iowa (CBB), Keystone Symposia, Inhibikase Therapeutics, Inc., and Kaleido Biosciences, Inc.</p> 1149</div> 1150</div> 1151</div> 1152</div> 1153</div> 1154</div> 1155</div> 1156<!--//team Management--><!--tech--> 1157 1158<div aria-hidden="true" aria-labelledby="tech" class="modal fade" id="techno" tabindex="-1"> 1159<div class="modal-dialog modal-xl modal-dialog-centered"> 1160<div class="modal-content "> 1161<div class="modal-body"><button aria-label="Close" class="btn-close close" data-bs-dismiss="modal" style="background: #414D9E; border-radius: 100%; width: 30px; height: 30px; color: #fff; " type="button">X</button> 1162 1163<div class="container ptb20"> 1164<div class="row"> 1165<div class="col-sm-12"> 1166<h2 class="clrbl">TECHNOLOGY</h2> 1167 1168<p>There is nothing more important than making people live healthy and longer lives. Check how BioXcel’s AI platform is extending the gift of science to people.</p> 1169 1170<h2 class="clrbl">EvolverAI</h2> 1171 1172<p>By utilizing this powerful AI platform EvolverAI, BioXcel Therapeutics successfully developed the first candidate medicine, IGALMI™ (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Our company performed this task in a matter of four years. We ensured that this medicine reached the patients and addressed a significant unmet need among patients and caregivers.</p> 1173 1174<p>At BioXcel, we are constantly working towards significantly reducing the bottlenecks associated with drug development, and identifying safe and well tolerated drugs for humans. We take on this responsibility by utilizing our AI-based platform EvolverAI for maximizing time advantage. EvolverAI efficiently carries out the analysis of big data through its deep learning algorithms. Its purpose is to bring to life our vision of changing the landscape of pharmaceutical research and development (R&D) by decoding therapeutic agents and disease biology. Our AI/ML algorithms are trained for model construction that aid in the identification of relevant repurposing prospects.</p> 1175 1176<p>Our platform is decoding many therapeutic possibilities of a drug compound by the unique combination of subject matter experts and AI platform. We are hopeful that with the help of our AI platform, we are only steps away from incredible innovations that will not only cut short the time, but also the costs and risks associated with drug development. This will eventually lead to expanding the pipeline of potentially life-saving drug discoveries</p> 1177</div> 1178</div> 1179</div> 1180</div> 1181</div> 1182</div> 1183</div> 1184<!--//tech--></body> 1185</html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.